Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kerstin Hiesinger"'
Autor:
Steffen Brunst, Julia Schönfeld, Peter Breunig, Luisa D. Burgers, Murphy DeMeglio, Johanna H. M. Ehrler, Felix F. Lillich, Lilia Weizel, Jasmin K. Hefendehl, Robert Fürst, Ewgenij Proschak, Kerstin Hiesinger
Publikováno v:
ACS Medicinal Chemistry Letters. 13:1062-1067
Soluble epoxide hydrolase (sEH) is a promising target for a number of inflammation-related diseases. In addition, inhibition of sEH has been shown to reduce neuroinflammation, which plays a critical role in the development of central nervous system (
Autor:
René Blöcher, Kerstin Hiesinger, Sandra K. Wittmann, Jana Gerstmeier, Denys Pogoryelov, Annika Schott, Ewgenij Proschak, Finja Witt, Dieter Steinhilber, Oliver Werz, Jan S. Kramer
Publikováno v:
ACS Medicinal Chemistry Letters. 11:298-302
Multitarget anti-inflammatory drugs interfering with the arachidonic acid cascade exhibit superior efficacy. In this study, a prototype dual inhibitor of soluble epoxide hydrolase (sEH) and LTA4 hy...
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Autor:
Stefano Woltersdorf, Thomas Duflot, Christophe Morisseau, Victor Hernandez-Olmos, Ewgenij Proschak, Apirat Chaikuad, Franca-M Klingler, Sandra K. Wittmann, Felix Knöll, Dieter Steinhilber, Jan S. Kramer, Felix F Lillich, Angelo Sala, Kerstin Hiesinger, Daniel Merk, Sylvain Fraineau, Jeremy Bellien, Bruce D. Hammock, Jan Heering, Steffen Brunst, Stefan Knapp, G. Enrico Rovati, Julie Rondeaux, Denys Pogoryelov, Carola Buccellati, Matthieu Leuillier
Publikováno v:
J Med Chem
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2019, 62 (18), pp.8443-8460. ⟨10.1021/acs.jmedchem.9b00445⟩
Journal of medicinal chemistry, vol 62, iss 18
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (18), pp.8443-8460. ⟨10.1021/acs.jmedchem.9b00445⟩
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2019, 62 (18), pp.8443-8460. ⟨10.1021/acs.jmedchem.9b00445⟩
Journal of medicinal chemistry, vol 62, iss 18
Journal of Medicinal Chemistry, American Chemical Society, 2019, 62 (18), pp.8443-8460. ⟨10.1021/acs.jmedchem.9b00445⟩
International audience; The emerging pharmacological target soluble epoxide hydrolase (sEH) is a bifunctional enzyme exhibiting two different catalytic activities that are located in two distinct domains. Although the physiological role of the C-term
Publikováno v:
Journal of medicinal chemistry. 64(1)
Spirocyclic scaffolds are incorporated in various approved drugs and drug candidates. The increasing interest in less planar bioactive compounds has given rise to the development of synthetic methodologies for the preparation of spirocyclic scaffolds
Autor:
Kerstin Hiesinger, Whitney Kilu, Steffen Brunst, Jan S. Kramer, Dieter Steinhilber, Sven George, Julius Pollinger, Jan Heering, Ewgenij Proschak, Daniel Merk
Publikováno v:
Chemmedchem
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and fragment‐based strategies have been postulated as a versatile avenue to discover multitarget ligand leads. To systematically probe the potential of frag
Autor:
Bettina Hofmann, Kerstin Hiesinger, Steffen Brunst, Timon Eckes, Carlo Angioni, Ewgenij Proschak, Dieter Steinhilber, Jan S. Kramer, Manfred Schubert-Zsilavecz, Gerd Geisslinger, Achim Schmidtko, Josef Pfeilschifter, Simon B.M. Kretschmer, Lilia Weizel, Sandra K. Wittmann, Sven George, Stephanie Schwalm, Sandra Beyer, Jan Heering, Cathrin Flauaus, Astrid Kaiser, Denys Pogoryelov
Publikováno v:
Journal of medicinal chemistry. 63(20)
Inhibition of multiple enzymes of the arachidonic acid cascade leads to synergistic anti-inflammatory effects. Merging of 5-lipoxygenase (5-LOX) and soluble epoxide hydrolase (sEH) pharmacophores led to the discovery of a dual 5-LOX/sEH inhibitor, wh
Publikováno v:
ACS Med Chem Lett
[Image: see text] Multitarget ligands are interesting candidates for drug discovery and development due to improved safety and efficacy. However, rational design and optimization of multitarget ligands is tedious because affinity optimization for two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2513a6708ca6015ff32d7afcdda5fa81
https://publica.fraunhofer.de/handle/publica/267020
https://publica.fraunhofer.de/handle/publica/267020
Autor:
Kerstin, Hiesinger, Annika, Schott, Jan S, Kramer, René, Blöcher, Finja, Witt, Sandra K, Wittmann, Dieter, Steinhilber, Denys, Pogoryelov, Jana, Gerstmeier, Oliver, Werz, Ewgenij, Proschak
Publikováno v:
ACS Med Chem Lett
[Image: see text] Multitarget anti-inflammatory drugs interfering with the arachidonic acid cascade exhibit superior efficacy. In this study, a prototype dual inhibitor of soluble epoxide hydrolase (sEH) and LTA(4) hydrolase (LTA(4)H) with submicromo
Autor:
Kerstin Hiesinger, Jan S. Kramer, Janosch Achenbach, Daniel Moser, Julia Weber, Sandra K. Wittmann, Christophe Morisseau, Carlo Angioni, Gerd Geisslinger, Astrid S. Kahnt, Astrid Kaiser, Anna Proschak, Dieter Steinhilber, Denys Pogoryelov, Karen Wagner, Bruce D. Hammock, Ewgenij Proschak
Publikováno v:
ACS Med Chem Lett
ACS medicinal chemistry letters, vol 10, iss 6
ACS medicinal chemistry letters, vol 10, iss 6
[Image: see text] Selective optimization of side activities is a valuable source of novel lead structures in drug discovery. In this study, a computer-aided approach was used to deorphanize the pleiotropic cholesterol-lowering effects of the beta-blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d0bd79212ad879a0f7127a657eeefd
https://publica.fraunhofer.de/handle/publica/258815
https://publica.fraunhofer.de/handle/publica/258815
Over the last two decades polypharmacology has emerged as a new paradigm in drug discovery, even though developing drugs with high potency and selectivity toward a single biological target is still a major strategy. Often, targeting only a single enz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadc0c5679bd6b902ca9c4beba673f25
https://europepmc.org/articles/PMC6345559/
https://europepmc.org/articles/PMC6345559/